Latest period
$83.31B
YoY change
-4.7%
5Y CAGR
+8.9%
Peak year (2023)
$90.92B
Latest annual
$81.93B
Total Liabilities history chart for Amgen (AMGN) from 1985 to 2025
Latest: $81.93B
Total Liabilities growth chart for Amgen (AMGN) from 1985 to 2025
Latest: -4.7%
Total Liabilities history table for Amgen (AMGN) from 1985 to 2025
| 2025 | $81.93B | -4.7% | −$4.03B | ||
| 2024 | $85.96B | -5.5% | −$4.96B | ||
| 2023 | $90.92B | +47.9% | +$29.46B | ||
| 2022 | $61.46B | +12.8% | +$7.00B | ||
| 2021 | $54.47B | +1.7% | +$926.00M | ||
| 2020 | $53.54B | +7.0% | +$3.50B | ||
| 2019 | $50.03B | -7.2% | −$3.88B | ||
| 2018 | $53.92B | -1.5% | −$797.00M | ||
| 2017 | $54.71B | +14.6% | +$6.96B | ||
| 2016 | $47.75B | +10.1% | +$4.38B | ||
| 2015 | $43.37B | +0.3% | +$135.00M | ||
| 2014 | $43.23B | -1.8% | −$798.00M | ||
| 2013 | $44.03B | +24.9% | +$8.79B | ||
| 2012 | $35.24B | +18.1% | +$5.40B | ||
| 2011 | $29.84B | +52.7% | +$10.30B | ||
| 2010 | $19.54B | +15.2% | +$2.58B | ||
| 2009 | $16.96B | +5.6% | +$905.00M | ||
| 2008 | $16.06B | -4.3% | −$713.00M | ||
| 2007 | $16.77B | +13.1% | +$1.95B | ||
| 2006 | $14.82B | +67.6% | +$5.98B | ||
| 2005 | $8.85B | -7.0% | −$670.00M | ||
| 2004 | $9.52B | +41.5% | +$2.79B | ||
| 2003 | $6.72B | +9.0% | +$554.00M | ||
| 2002 | $6.17B | +403.3% | +$4.94B | ||
| 2001 | $1.23B | +13.0% | +$140.80M | ||
| 2000 | $1.09B | +2.9% | +$31.00M | ||
| 1999 | $1.05B | -5.0% | −$55.90M | ||
| 1998 | $1.11B | +14.3% | +$139.10M | ||
| 1997 | $970.90M | +13.0% | +$111.60M | ||
| 1996 | $859.30M | +12.9% | +$98.30M | ||
| 1995 | $761.00M | +5.7% | +$41.20M | ||
| 1994 | $719.80M | +21.3% | +$126.30M | ||
| 1993 | $593.50M | +34.7% | +$152.90M | ||
| 1992 | $440.60M | +31.8% | +$106.20M | ||
| 1991 | $334.40M | +188.3% | +$218.40M | ||
| 1990 | $116.00M | — | — | ||
| 1988 | $45.20M | +54.3% | +$15.90M | ||
| 1987 | $29.30M | +128.9% | +$16.50M | ||
| 1986 | $12.80M | -2.3% | −$300.00K | ||
| 1985 | $13.10M | — | — |
- 2025$81.93B-4.7%
- 2024$85.96B-5.5%
- 2023$90.92B+47.9%
- 2022$61.46B+12.8%
- 2021$54.47B+1.7%
- 2020$53.54B+7.0%
- 2019$50.03B-7.2%
- 2018$53.92B-1.5%
- 2017$54.71B+14.6%
- 2016$47.75B+10.1%
- 2015$43.37B+0.3%
- 2014$43.23B-1.8%
- 2013$44.03B+24.9%
- 2012$35.24B+18.1%
- 2011$29.84B+52.7%
- 2010$19.54B+15.2%
- 2009$16.96B+5.6%
- 2008$16.06B-4.3%
- 2007$16.77B+13.1%
- 2006$14.82B+67.6%
- 2005$8.85B-7.0%
- 2004$9.52B+41.5%
- 2003$6.72B+9.0%
- 2002$6.17B+403.3%
- 2001$1.23B+13.0%
- 2000$1.09B+2.9%
- 1999$1.05B-5.0%
- 1998$1.11B+14.3%
- 1997$970.90M+13.0%
- 1996$859.30M+12.9%
- 1995$761.00M+5.7%
- 1994$719.80M+21.3%
- 1993$593.50M+34.7%
- 1992$440.60M+31.8%
- 1991$334.40M+188.3%
- 1990$116.00M—
- 1988$45.20M+54.3%
- 1987$29.30M+128.9%
- 1986$12.80M-2.3%
- 1985$13.10M—
Total Liabilities values are taken from Amgen's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's latest reported total liabilities is $83.31B. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total liabilities for Amgen (AMGN) came in at $81.93B – edged down 4.7% year-over-year.
Across 2020–2025 (5 years), Amgen total liabilities produced a CAGR of +8.9% – with mixed annual results across the window.
2023 marks the peak total liabilities at $90.92B, with the historical low of $12.80M recorded in 1986.
Amgen Total Liabilities by Year
Amgen Total Liabilities 2025: $81.93B
2025's total liabilities for Amgen came in at $81.93B, edged down 4.7% below 2024.
Amgen Total Liabilities 2024: $85.96B
Amgen posted total liabilities of $85.96B in 2024, declined 5.5% below 2023.
Amgen Total Liabilities 2023: $90.92B
In 2023, Amgen reported total liabilities of $90.92B, surged 47.9% from 2022. This figure represents the highest annual value in the available history.
Amgen Total Liabilities 2022: $61.46B
Amgen total liabilities in 2022 was $61.46B, grew 12.8% from 2021.
Amgen Total Liabilities 2021: $54.47B
Amgen total liabilities in 2021 was $54.47B.
See more financial history for Amgen (AMGN).
Sector peers by Total Liabilities
Healthcare peers of Amgen (AMGN), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $65.36B | |
| $56.81B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $65.36B
- $54.86B
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation